Introduction: Ceftriaxone, a third-generation cephalosporin, is frequently used for the treatment of various bacterial infections as a broad-spectrum antibiotic for many decades. Although ceftriaxone is a well-tolerated drug in most cases, it can lead to serious liver injury, which can be a real challenge to the treating physician. Given the potentially serious adverse effects that can vary from mild biochemical abnormalities to complete liver failure, we intend to assess the spectrum of liver injury based on biochemical criteria for patients treated with ceftriaxone for common bacterial infections in Qatar.Objectives: This study aimed to explore the incidence of ceftriaxone-induced liver injury at Hazm Mebaireek General Hospital, Qatar, and to evaluate the relationship of the ceftriaxone dose, if any, with liver dysfunction.Methods: This retrospective study included hospitalized adult patients treated with ceftriaxone at our hospital from January 2019 to December 2019 and analyzed demographic and clinical data obtained from electronic medical records. This study determined the incidence of liver injury (primary outcome) in patients treated with ceftriaxone (2 g/day) for ≥ 2 consecutive days by reviewing liver function test results until the day of discharge and at the first outpatient follow-up. Results: The final data analysis included a total of 634 patients admitted and treated with ceftriaxone from January 2019 to December 2019.In the multivariate analysis with propensity score adjustment, ceftriaxone was independently associated with liver injury, especially when combined with other agents utilizing hepatic metabolism.Conclusions: Ceftriaxone was associated with a significantly higher incidence of liver injury (19.7%) when used along with other medications that are metabolized in the liver, as found in the present study compared with other similar studies (approximately 2.9%–13.9%). Furthermore, the incidence was too high to be ignored in clinical practice.
Premodern Muslim juristic discussions on religious innovation (bidʿa) frequently invoke a distinction between religion and its other: the irreligious and/or non-religious secular. This demarcation disrupts accounts of the unavailability of the secular beyond the precincts of the modern West, even as the imperfect translation of premodern Islamic non-religion as secular discloses the ethnocentric provincialism of the master categories of European thought that continue to facilitate European colonialism. An alternative, premodern, Islamic account of the secular is found in the thought of Ibn Taymiyya (d. 728/1328), al-Shāṭibī (d. 790/1388) and their intergenerational interlocutors who summon an opaque and shifting, yet real, boundary between religion and the irreligious and/or non-religious secular, which they posit as distinct, oppositional, yet also co-constitutive terms. The distinctions between religion and the secular, for these scholars, arise out of their (i) purposive account of divine law, (ii) compartmentalization of religious ‘worship’ from secular ‘custom’, and (iii) creation of distinct orders of religious and secular spatio-temporality.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.